MSD

mk7655A

Biodrugs/ Drugs
Infections
Phase III Pembrolizumab Plus Lenvatinib Versus Chemotherapy for the First-line Treatment of Persistent, Recurrent or Metastatic Endometrial Carcinoma
3Phase III in Spain, 2Phase II in Spain, 1Phase I